Amphastar Pharmaceuticals (AMPH) Non-Current Deferred Tax Liability (2016 - 2023)
Amphastar Pharmaceuticals (AMPH) has 11 years of Non-Current Deferred Tax Liability data on record, last reported at $201000.0 in Q3 2023.
- For Q3 2023, Non-Current Deferred Tax Liability fell 16.94% year-over-year to $201000.0; the TTM value through Sep 2023 reached $201000.0, down 16.94%, while the annual FY2022 figure was $144000.0, 73.03% down from the prior year.
- Non-Current Deferred Tax Liability reached $201000.0 in Q3 2023 per AMPH's latest filing, roughly flat from $201000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $2.9 million in Q3 2021 and bottomed at $144000.0 in Q4 2022.
- Average Non-Current Deferred Tax Liability over 5 years is $724222.2, with a median of $748000.0 recorded in 2020.
- Peak YoY movement for Non-Current Deferred Tax Liability: surged 252.49% in 2021, then plummeted 91.66% in 2022.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $867000.0 in 2019, then decreased by 14.53% to $741000.0 in 2020, then fell by 27.94% to $534000.0 in 2021, then crashed by 73.03% to $144000.0 in 2022, then skyrocketed by 39.58% to $201000.0 in 2023.
- Per Business Quant database, its latest 3 readings for Non-Current Deferred Tax Liability were $201000.0 in Q3 2023, $201000.0 in Q2 2023, and $178000.0 in Q1 2023.